CPDN is pleased to announce the following appointments to its Board of Directors

Effective Feb 1, 2024, Kirill Vendrov, currently Director, Established Medicines Group & Corporate Accounts at Johnson & Johnson Innovative Medicine, is appointed CPDN Board Chair responsible for leading the CPDN Board in carrying out its corporate governance and fiduciary duties. Kirill has served on the CPDN Board since 2020 and brings a wealth of knowledge and experience in pharmaceutical supply chain and commercial strategy.

In addition, Stefan Georg Lindinger, currently VP Finance & Business Services (CFO) at Roche Canada, has been appointed to the Board of Directors. Stefan brings a diverse knowledge of financial operations from both Europe and North America and succeeds Gregoire de Mierry from Roche, who was CPDN Board Chair for 3 years. CPDN thanks Gregoire for his dedicated service, stewardship and guidance on the CPDN Board and wishes him well in his future endeavours.

The CPDN Board members also include Denis Tremblay, Director Customer Relations at Pfizer Canada, Heather McDonald, VP Market Access & Pricing at AstraZeneca Canada, and Rob White, Director of Market Access & Payer Solutions at GSK. The CPDN Board Secretary is Amanda Kazmierczak, currently Legal Analyst at Roche Canada.

Sav DiPasquale,
President, CPDN